A Study to Evaluate the Efficacy and Safety of JCAR017 in Adult Subjects With Relapsed or Refractory Indolent B-cell Non-Hodgkin Lymphoma (NHL)

PHASE2RecruitingINTERVENTIONAL
Enrollment

276

Participants

Timeline

Start Date

July 14, 2020

Primary Completion Date

September 30, 2031

Study Completion Date

September 30, 2031

Conditions
Lymphoma, Non-Hodgkin
Interventions
DRUG

Fludarabine

Fludarabine

DRUG

Cyclophosphamide

Cyclophosphamide

DRUG

JCAR017

JCAR017

Trial Locations (59)

1090

RECRUITING

Allgemeinen Krankenhaus (AKH) Wien - Medizinische Universitaet Wien, Vienna

8035

WITHDRAWN

Local Institution - 352, Barcelona

10021

RECRUITING

Memorial Sloan Kettering Cancer Center, New York

12203

WITHDRAWN

Local Institution - 506, Berlin

14186

RECRUITING

Karolinska Hospital, Stockholm

15232

WITHDRAWN

Local Institution - 126, Pittsburgh

19104

RECRUITING

University of Pennsylvania - Perelman Center for Advanced Medicine, Philadelphia

21201

RECRUITING

University of Maryland - Greenebaum Comprehensive Cancer Center, Baltimore

22903

RECRUITING

University Of Virginia Health System, Charlottesville

24105

WITHDRAWN

Local Institution - 505, Kiel

24127

RECRUITING

Azienda Ospedaliera Papa Giovanni Xxiii, Bergamo

28007

RECRUITING

Hospital General Universitario Gregorio Marañon, Madrid

28204

RECRUITING

Novant Health Presbyterian Medical Center, Charlotte

31100

RECRUITING

Institut Universitaire du Cancer Toulouse - Oncopole - CHU de TOULOUSE, Toulouse

33021

WITHDRAWN

Local Institution - 0601, Hollywood

33136

WITHDRAWN

Washington University School Of Medicine, Miami

34295

RECRUITING

CHU Montpellier - Hôpital Saint Eloi, Montpellier

35023

RECRUITING

Centre Hospitalier Universitaire de Rennes - Hopital Pontchaillou, Rennes

37007

RECRUITING

Hospital Universitario de Salamanca - Complejo Asistencial Universitario de Salamanca, Salamanca

37920

WITHDRAWN

Local Institution - 125, Knoxville

40138

WITHDRAWN

Local Institution - 302, Bologna

41013

RECRUITING

Hospital Virgen Del Rocio, Seville

44195

RECRUITING

Cleveland Clinic Foundation, Cleveland

48201

RECRUITING

Karmanos Cancer Center, Detroit

48202

WITHDRAWN

Local Institution - 118, Detroit

50937

RECRUITING

University Hospital Cologne, Cologne

52242

RECRUITING

University Of Iowa, Iowa City

57105

COMPLETED

Local Institution - 113, Sioux Falls

58122

WITHDRAWN

Local Institution - 120, Fargo

59037

RECRUITING

CHRU-Hopital Claude Huriez, Lille

60611

RECRUITING

Northwestern University, Chicago

60714

COMPLETED

Local Institution - 109, Niles

67124

RECRUITING

Cancer Center of Kansas, Wichita

69495

RECRUITING

Centre Hospitalier Lyon-Sud, Pierre-Bénite

75475

RECRUITING

Hopital Saint Louis, Paris

76135

RECRUITING

Stadtisches Klinikum Karlsruhe, Karlsruhe

77030

RECRUITING

Houston Methodist Hospital, Houston

RECRUITING

The University of Texas - MD Anderson Cancer Center, Houston

80045

RECRUITING

University Of Colorado Cancer Center, Aurora

80131

RECRUITING

Istituto Nazionale Per Lo Studio E La Cura Dei Tumori Fondazione Giovanni Pascale, Naples

81377

RECRUITING

LMU Klinikum der Universitat Munchen, Munich

89081

RECRUITING

Universitaetsklinikum Ulm, Ulm

90095

RECRUITING

UCLA Medical Centre-Santa Monica, Santa Monica

93053

RECRUITING

Universitätsklinikum Regensburg, Regensburg

97213

RECRUITING

Providence Cancer Center/Earle A. Chiles Res. Inst., Portland

98109

RECRUITING

Fred Hutchinson Cancer Center, Seattle

1040045

ACTIVE_NOT_RECRUITING

Local Institution - 550, Chuo-ku

06520

RECRUITING

Yale Cancer Center, New Haven

02114

RECRUITING

Massachusetts General Hospital - Dana-Farber Cancer Institute, Boston

02215

RECRUITING

Beth Israel Deaconess Medical Center, Boston

07960

RECRUITING

Atlantic Health System Morristown Medical Center, Morristown

75230-2510

RECRUITING

Texas Oncology, Dallas

M5G 2M9

RECRUITING

Princess Margaret Cancer Centre, Toronto

H1T 2M4

RECRUITING

Hopital Maisonneuve - Rosemont, Montreal

0608648

ACTIVE_NOT_RECRUITING

Local Institution - 553, Sapporo

105-8470

COMPLETED

Local Institution - 551, Minato-ku

812-8582

COMPLETED

Local Institution - 552, Fukuoka

NW1 2PG

RECRUITING

University College London Hospitals NHS Foundation Trust - University College Hospital, London

M20 4BX

RECRUITING

The Christie NHS Foundation Trust, Manchester

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Celgene

INDUSTRY

NCT04245839 - A Study to Evaluate the Efficacy and Safety of JCAR017 in Adult Subjects With Relapsed or Refractory Indolent B-cell Non-Hodgkin Lymphoma (NHL) | Biotech Hunter | Biotech Hunter